Healthcare | March 20, 2024
Aster’s India and GCC business separation nearing completion
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
A five-day inspection was concluded successfully with no critical and no major observations raised
Additional capacity broadens Grace’s fine chemical capabilities for API production
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Both organisations enter into a long- term collaboration to expand patient access in India
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
More than 10,000 scientific publications containing EUDRAGIT
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Subscribe To Our Newsletter & Stay Updated
